PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Genoscience Pharma, 13006 Marseille, France.\', \'Institut de Recherche Pour le Développement, Aix-Marseille University, Assitance Publique-Hopitaux de Marseille, Microbe, Phylogeny and Infection, 13005 Marseille, France.\', \'Institut Hospitalo-Universitaire Méditerranée Infection, Aix-Marseille University, 13005 Marseille, France.\', \'Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.\', \'Lille University, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, Centre d\'Infection et d\'Immunité de Lille (CIIL), INSERM U 1019-UMR 9017-UMR 8204, 59019 Lille, France.\', \'Department of Pathology, La Timone Hospital, Aix-Marseille Université, 13005 Marseille, France.\']
?:citedBy
  • -1
?:creator
?:doi
  • 13210.3390/v14010132
?:doi
?:hasPublicationType
?:journal
  • Viruses
is ?:pmid of
?:pmid
?:pmid
  • 35062337
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.805
?:rankingScore_hIndex
  • 52
is ?:relation_isRelatedTo_publication of
?:title
  • GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all